Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry - You'll need to buy at least 500 shares to get 1, since they will do a 1:500. And how does a R/S turn into a profit? I don't understand.
@Superones - I understand your comments about shorting the stock, (and no I am not shorting it). However, I certainly think that the management of a company that purports to want to help cancer victims, and then stands idly by while its share price is virtually decimated (while at the same time drawing obscene salaries, and perhaps even actively participating in the demise of said share price) bears some responsibility as well. In fact, given that they have a fiduciary duty to their shareholders, (many of whom may very well have "invested" in the company precisely because of situations like you or their friends or loved ones are in), I would make the argument that the management is cast in an even more evil light than those who are shorting the stock.
@Rap - I see your point. Closure of the trial could simply mean that that they've collected all of the data they needed from that particular trial. Why continue at more expense if the goal has been met?
Institutional holders from latest Form 13 filing.
This came across my news feed earlier this morning:
My first thought was - Is this some kind of joke?
Delcath Systems Inc, Inst Holders, 1Q 2018 (DCTH)
DOW JONES & COMPANY, INC. 3:36 AM ET 4/20/2018
The following table shows the largest shareholders in DELCATH SYSTEMS INC COM (DCTH) for the quarter ended March 31, 2018, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 03/31/2018
Institution Shares Shares % Last
Held Changed Held Report
West Oak Capital LLC 25,000 25,000 0.006 03/31
Gemmer Asset Management LLC 1 1 0.000 12/31
IFP Advisors Inc. 0 (376) 0.000 12/31
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2018. All Rights Reserved.
(END) Dow Jones Newswires
04-20-180336ET
Just came across the newswire now:
PHILADELPHIA , April 18, 2018 /PRNewswire/ -- Integrated Ventures, Inc. (the "Company") today announced that it has entered into an Asset Purchase Agreement ("APA") with digiMINE, LLC, to acquire certain cryptocurrency assets, consisting of (1) 150 assorted ASIC miners and related mining equipment and (2) $175,000 in cash, to be used for the purchase of 145 assorted Antminers by Bitmain Technologies. The remaining capital will be deployed for the build out for the 5,900 sq ft warehouse facility, located in Marlboro, NJ.
Following the completion of this equity based and non-dilutive acquisition, Integrated Ventures(INTV) will own and operate 650 assorted cryptocurrency miners, consisting of Antminer S9, Antminer L3, Antminer X3, Antminer A3, Nemesis 8G and Panda B3 Pro models.
Pursuant to the executed APA, the aggregate consideration for all the assets being acquired, consist of 16,666 Restricted Preferred B Shares, to be issued to the digiMINE, LLC.
According to the terms of this equity based APA, the Company will acquire rights to the multi-year lease agreement between digiMINE, LLC and warehouse facility, equipped with 4,000 amp power capacity and capable of hosting up to 1,500 mining rigs.
The Company is in final stages of consolidating of its mining operations according to the following plan:
INTV will maintain all mining operations at Buck Rd, PA (Location 1)
INTV is relocating all mining equipment from Armstrong St, PA to Paul St, PA (Location 2)
INTV will commence mining operations at Boundary St, NJ, by the middle of June (Location 3).
As result, the total hosting capacity, between all locations is expected to reach 2,500 units.
Steve Rubakh , CEO of Integrated Ventures, Inc(INTV), comments: "We are very excited about this non-dilutive transaction and Company's prospects going forward. Our Q3, which is scheduled by be filed by 05/15/2018, will disclose zero dilution and convertible debt, solid cash position and increase in revenue generating mining assets. For past 60 days, the focus has been on streamlining mining operations and adding mining power capacity. In addition, our team is panning on launching a number of a blockchain powered initiatives, designed to improve profitability and efficiency of cryptocurrency mining operations."
The closing of the APA is subject to customary closing conditions and is expected to close on or before April 20, 2018. The Company intends to file Form 8-K within 4 days of signing this APA..
About Integrated Ventures Inc(INTV): Integrated Ventures (INTV) is focused on acquiring, launching and operating companies in the cryptocurrency sector ("BitcoLab"), mainly in digital currency mining, equipment manufacturing, sales of branded mining rigs ("Nemesis") and blockchain software development ("LoanFunder").
For more details, please visit www.integratedventuresinc.com.
You do realize that email is nearly 1 year old, right??
@Nate - Really??? Using a market order - especially on OTC? Who does that????
@Leo - I think the fact that they filed the 8K means its approved. I expect an announcement soon that the BOD "...has determined that a 1:500 R/S is in the best interest of the company and the shareholders"
Face it. We've been Delcathed!!
@Rap - So in a few weeks, you'll have to change your tagline to "1850 shares strong and holding"
We're screwed. Shorts win again.
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc.(DCTH) , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that shareholders have approved the provisions of the Company’s Consent Solicitation filed with the Securities Exchange Commission (SEC) on February, 26, 2018. By a vote of 54.3%, shareholders as of the record date of February 9, 2018 approved the Company’s proposals to amend its certificate of incorporation to increase its authorized shares of common stock from 500,000,000 to 1,000,000,000 (the Authorized Share Increase), and, by a vote of 52.8%, to effect a reverse stock split of the Company’s common stock at a range of 1-for-100 to 1-for-500 (the Reverse Stock Split Authorization).
As a result, the Board of Directors is authorized to determine, in its sole discretion, whether to implement the reverse stock split at a ratio within the approved range, as well as its specific timing, but not later than April 6, 2019.
@Rap, Well, except for maybe not putting out any positive news of significance, or any attempt to prop the share price up while HB and others were shorting it into oblivion after the forced-R/S. But, of course, that apparently was part of the plan. The plan that none of us were privy to.
@Jmd6118 - Isn't it a bit premature to say "the longs have won this one"? I hope you're right, but we don't know that for a fact yet. GLTA!
@DE - Very well said! From a business perspective, the actions of the BOD are indefensible. To stand by and literally watch the share price be decimated, making no attempt whatsoever to communicate with shareholders, or to stop the bleeding suggests a callous disregard for the people who have invested in this. With no "skin in the game" of their own (as evidenced by the lack of filings showing BOD open market purchases of stock), they had no incentives to do anything other than the same-old thing with HB, Ayrton, and now Roth. If I was CEO or any executive officer of a publicly traded company, I would be embarrassed to show the share ownership levels that these people have listed in their filings.
From everything I've seen, they have clearly abrogated their fiduciary duty to shareholders.
@H2004 - DCTH: It's groundhog day for terrible trades. Let's hope that Punxsutawney Phil doesn't see his shadow and spikes this thing upward as he exits his burrow
@H2004 - Or, perhaps a quaint little English Tudor, surrounded by a bevy of shrubberies, meticulously planted and maintained by "Eric the Shrubber"
@Leo - I tend to agree with your prediction. From my perspective, there are a few observations that have lead me to think that the vote was a NO.
1. Voting ended at the scheduled time. I think if they had enough votes prior to the deadline, they would have issued a PR stating that they had enough Yes votes to pass the measure(s).
2. No announcement of an extension to the solicitation period
3. They would likely have known the outcome well before COB today, because most votes were probably cast online, and any mail-in votes would likely have been tallied as received.
Assuming they knew, why would they not issue a PR today with the results? My guess is that the vote was NO and they need the weekend to huddle with their attorneys to devise some kind of strategy on how to overturn the results.
Obviously, this is all speculation, but what the heck, it's Friday night and we might as well dream up scenarios for what happens this week.
@bassclef - Uh.... Not exactly. They've been short for a while now. They will need to cover if news is that the R/S failed...
@DE - The degree of northward movement today will be inversely proportionate to the size of the shorties' cajones!!!
@RDW - I'm guessing that an extension is not in the cards. Just for grins, I looked at proxyvote.com this morning and it shows that the vote is now closed (for internet voting). I would think if an extension was being announced that they would have left it open. I would have also expected a PR this morning if an extension was being announced, since the vote is supposed to be closed at the end of business today. Having said all that, however, we must remember that this is DCTH after all, so "Anything Goes"!!
@Rap - No confusion. You are correct. Internet voting deadline is now at 11:59 PM, APR 5, not May 5 as DE posted. IDK where that came from unless it was a typo. Actual meeting is tomorrow, and DE was right about the fact that mail in or walk-in votes can be received up to 5PM tomorrow. Based on that, I would not expect to see a PR until after 5PM tomorrow unless the majority of shares had already been voted prior to the meeting and any remaining votes would not change the outcome.
@H2004 - That's it!!! The earth moved!! That can only mean one thing.... Jenny-O decided to do right by the shareholders. Must be something good coming....
So is it just me, or has the volume on this just crawled to non-existent in the last half hour? L2 seems to be dried up with CDEL sitting on the bid with 545,000 at 0.0102 and MAXM at 0.0105 with 10,000 on the ask.
@Rap - Maybe we can staple this post. Let me get out my red Swingline stapler. It's a real beauty.
@SNS - Just curious: If the vote was yes by a large margin, don't you think they would have issued a PR and closed the vote already by now? They are allowed to do that if they have enough votes before the voting period ends.
Yes - You can vote online at www.proxyvote.com You'll need the control number which is assigned to you and is in the proxy materials you should have received. If you didn't get anything, contact your broker.
@AuthorMaze - So you're one of the "lucky ones". Many of us are down more than 90%. At this point, I'm looking to recover what I can if we get a pop soon in the event of a No on the R/S proposal. For my part, this is and always has been a very speculative play, so I set my investment level accordingly. GLTY!
@modrica - I think I figured out why you call her Juwanna. It's kind of like she's always telling us "Juwanna your money back? Sorry - You can't have it because I've spent most of it and the rest is in offshore accounts"
@Sam - While I certainly agree that Right to Try could open up a huge opportunity in the marketplace, I'm afraid that it will be too little too late. If the R/S goes thru as planned, anyone holding long thru it is going to be wiped out again such that no amount of new opportunity in the marketplace is going to be enough to allow us recover from it.
It's not going to move the SP, but it IS a PR, and since we don't see many of them, that in itself makes it newsworthy. Just came across the wire now:
Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc.(DCTH) , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that Dr. Brian Steadman, Interventional Oncologist at the Southampton University Hospital will present a video training session at the Annual Meeting of the European Conference of Interventional Oncology (ECIO). Dr. Steadman will present an overview of the Percutaneous Hepatic Perfusion (PHP) procedure and potential indications of PHP Therapy, as well as review recent research. The session will be held Tuesday, April 24, 2018 at 3pm local time.
The ECIO will be held in Vienna, Austria, April 22-25, 2018.
About Delcath Systems(DCTH)
Delcath Systems (DCTH), Inc. is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product – Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) – is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. We have commenced a global Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) and plan to initiate a Registration trial for intrahepatic cholangiocarcinoma (ICC). Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, our system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver.
Forward Looking Statements
Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to: the timing and results of the Company’s clinical trials including without limitation the OM and ICC clinical trial programs, timely enrollment and treatment of patients in the global Phase 3 OM clinical trial, IRB or ethics committee clearance of the Phase 3 OM and ICC Registration trial protocols from participating sites and the timing of site activation and subject enrollment in each trial, the impact of the presentations at major medical conferences and future clinical results consistent with the data presented, approval of Individual Funding Requests for reimbursement of the CHEMOSAT procedure, the impact, if any of ZE reimbursement on potential CHEMOSAT product use and sales in Germany, clinical adoption, use and resulting sales, if any, for the CHEMOSAT system to deliver and filter melphalan in Europe including the key markets of Germany and the UK, the Company’s ability to successfully commercialize the Melphalan HDS/CHEMOSAT system and the potential of the Melphalan HDS/CHEMOSAT system as a treatment for patients with primary and metastatic disease in the liver, our ability to obtain reimbursement for the CHEMOSAT system in various markets,, approval of the current or future Melphalan HDS/CHEMOSAT system for delivery and filtration of melphalan or other chemotherapeutic agents for various indications in the U.S. and/or in foreign markets, actions by the FDA or other foreign regulatory agencies, the Company’s ability to successfully enter into strategic partnership and distribution arrangements in foreign markets and the timing and revenue, if any, of the same, uncertainties relating to the timing and results of research and development projects, and uncertainties regarding the Company’s ability to obtain financial and other resources for any research, development, clinical trials and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.
Contact:
Delcath Investor Relations
Email: investorrelations@delcath.com
Source: Delcath Systems, Inc.(DCTH)
@GG - Please post the source of this information. I've seen no official release of that.
@RDW - Positive news, but I don't see it moving the stock much, it at all.
@GG. Really??? Perhaps you'd care to post some supporting documentation. Oh. You don't have any?? Why am I not surprised....
@JH - Timing is interesting, because form 8-K's are required to be filed within 4 days of a "material event". A "material event" being defined by the SEC as one which could affect the company's stock price or valuation.
@SAMNOTSAMUEL - You won't be laughing all the way to the bank if you have to hold through another R/S. I know it doesn't apply to you, but there are others here who it does apply to.
@H2004 - Thanks much! Best wishes to you as well. I sincerely hope that we get enough of a spike to exit with at least some of our skin intact! TWT....
@H2004 - Enjoy the Zin. Good choice. Currently, I'm sipping some 18 Year Old GlenLivet. Bottle is getting dangerously low and will need to be replenished soon....
@Trompete - How does giving a golden parachute to "Jenny and the jets" do anything to prevent a buyout? All it does is protect them if a BO occurs. It doesn't do anything to incentivize them to stop one from occurring. What am I missing here?
@Rap - Yeah, maybe. But the question of the day is.... Before or after the R/S (assuming it goes through)????
@DE - Well, if nothing else, the timing of the 8K is interesting. I don't recall seeing it previously.
@RDW - I completely agree. When entering into any stock transaction, there is, of course, no guarantee of a successful outcome. There is always risk involved, many times due to factors which are completely outside the company's control. It's always on us to perform whatever level of DD we believe is necessary to mitigate that risk. However, we do have a right to expect that when we enter into such a transaction in good faith, that there is in turn, a good faith effort on the part of the BOD and executives of the company to abide their fiduciary duty to the shareholders. I can accept the other risks, but when there is evidence of malfeasance on the part of the company management, that's when I have a real problem. If this BOD was performing their fiduciary duty, there is NO WAY IN HELL they would have allowed the SP to drop the way it did after the last R/S, and then turn around and try to do it again. What happened here stinks to high heaven of ruthless manipulation and clandestine backroom deals with HB, Ayrton and others. Actions, that IMHO, clearly do not align with the BOD's fiduciary responsibility to the shareholders.